tiprankstipranks
Trending News
More News >
CASI Pharmaceuticals (CASI)
NASDAQ:CASI
Advertisement

CASI Pharmaceuticals (CASI) Revenue

Compare
470 Followers

CASI Pharmaceuticals Revenue

CASI Pharmaceuticals had a revenue of 3.08M in the quarter ending Sep 30, 2025, with -26.35%. This bring the company's revenue in the last twelve months to 26.85M, Increased -14.95%. In the fiscal year ending Dec 31, 2024, CASI Pharmaceuticals had annual revenue of 28.54M with -15.77% growth.
Revenue (ttm)
26.85M
Revenue Growth
26.20%
P/S Ratio
0.72
Revenue/Employee
$122,476
Employees
233
Market Cap
$20.61M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
28.54M-5.34M+84.23%
Dec 31, 2023
33.88M-9.23M+78.59%
Dec 31, 2022
43.11M12.94M+142.89%
Dec 31, 2021
30.17M15.03M+199.25%
Dec 31, 2020
15.14M11.01M+366.52%
Dec 31, 2019
4.13M-413,100,000.00%
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis